FZ-AD004
/ Shanghai Fudan-Zhangjiang
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 23, 2026
A Study of FZ-AD004 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=121 | Recruiting | Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Trial completion date: Dec 2025 ➔ Dec 2027 | Trial primary completion date: Dec 2025 ➔ Dec 2026
First-in-human • Trial completion date • Trial primary completion date • Solid Tumor
May 20, 2024
A Study of FZ-AD004 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=121 | Recruiting | Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1